Inactivating mutation in the cell cycle regulator locus CDKN2A subsequently promotes a neurofibroma’s progression into a pre-malignant state called atypical neurofibroma of uncertain potential (ANNUBP). The gene discussed is CDKN2A; the disease is plexiform neurofibroma.